Solid Biosciences Inc. (SLDB)
NASDAQ: SLDB · Real-Time Price · USD
6.86
+0.70 (11.36%)
Jan 22, 2026, 4:00 PM EST - Market closed
Solid Biosciences Market Cap
Solid Biosciences has a market cap or net worth of $534.46 million as of January 23, 2026. Its market cap has increased by 226.26% in one year.
Market Cap
534.46M
Enterprise Value
320.26M
1-Year Change
226.26%
Ranking
Category
Stock Price
$6.86
Market Cap Chart
Since January 26, 2018, Solid Biosciences's market cap has decreased from $7.30B to $534.46M, a decrease of -92.68%. That is a compound annual growth rate of -27.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 534.46M | 21.63% |
| Dec 31, 2025 | 439.41M | 174.95% |
| Dec 31, 2024 | 159.82M | 29.00% |
| Dec 29, 2023 | 123.89M | 17.92% |
| Dec 30, 2022 | 105.06M | -45.57% |
| Dec 31, 2021 | 193.02M | -61.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jan 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Anavex Life Sciences | 444.06M |
| Assembly Biosciences | 439.72M |
| Eupraxia Pharmaceuticals | 438.09M |
| Vanda Pharmaceuticals | 437.32M |
| PureTech Health | 435.60M |
| ADC Therapeutics | 435.43M |
| Absci | 428.56M |
| 4D Molecular Therapeutics | 428.51M |